CD93 and chronic myelogenous leukemia, BCR-ABL1 positive: There was a significant decrease in CD93 expression with maturation from CD34+ to mononuclear cells (MNC) (p < 0.0001) in CML, indicating that high expression of CD93 may be a specific marker of primitive LSC in CML.